ID   MAGI3_MOUSE             Reviewed;        1476 AA.
AC   Q9EQJ9; B0V3N7; B0V3N8; Q69ZE1; Q8C0P8;
DT   10-JUN-2008, integrated into UniProtKB/Swiss-Prot.
DT   10-JUN-2008, sequence version 2.
DT   07-APR-2021, entry version 135.
DE   RecName: Full=Membrane-associated guanylate kinase, WW and PDZ domain-containing protein 3;
DE   AltName: Full=Membrane-associated guanylate kinase inverted 3;
DE            Short=MAGI-3;
GN   Name=Magi3; Synonyms=Kiaa1634;
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Mus; Mus.
OX   NCBI_TaxID=10090;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), FUNCTION, TISSUE SPECIFICITY, AND
RP   INTERACTION WITH TGFA.
RX   PubMed=15652357; DOI=10.1016/j.yexcr.2004.10.007;
RA   Franklin J.L., Yoshiura K., Dempsey P.J., Bogatcheva G., Jeyakumar L.,
RA   Meise K.S., Pearsall R.S., Threadgill D., Coffey R.J.;
RT   "Identification of MAGI-3 as a transforming growth factor-alpha tail
RT   binding protein.";
RL   Exp. Cell Res. 303:457-470(2005).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=C57BL/6J;
RX   PubMed=19468303; DOI=10.1371/journal.pbio.1000112;
RA   Church D.M., Goodstadt L., Hillier L.W., Zody M.C., Goldstein S., She X.,
RA   Bult C.J., Agarwala R., Cherry J.L., DiCuccio M., Hlavina W., Kapustin Y.,
RA   Meric P., Maglott D., Birtle Z., Marques A.C., Graves T., Zhou S.,
RA   Teague B., Potamousis K., Churas C., Place M., Herschleb J., Runnheim R.,
RA   Forrest D., Amos-Landgraf J., Schwartz D.C., Cheng Z., Lindblad-Toh K.,
RA   Eichler E.E., Ponting C.P.;
RT   "Lineage-specific biology revealed by a finished genome assembly of the
RT   mouse.";
RL   PLoS Biol. 7:E1000112-E1000112(2009).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 53-1355 (ISOFORM 2).
RC   STRAIN=C57BL/6J; TISSUE=Testis;
RX   PubMed=16141072; DOI=10.1126/science.1112014;
RA   Carninci P., Kasukawa T., Katayama S., Gough J., Frith M.C., Maeda N.,
RA   Oyama R., Ravasi T., Lenhard B., Wells C., Kodzius R., Shimokawa K.,
RA   Bajic V.B., Brenner S.E., Batalov S., Forrest A.R., Zavolan M., Davis M.J.,
RA   Wilming L.G., Aidinis V., Allen J.E., Ambesi-Impiombato A., Apweiler R.,
RA   Aturaliya R.N., Bailey T.L., Bansal M., Baxter L., Beisel K.W., Bersano T.,
RA   Bono H., Chalk A.M., Chiu K.P., Choudhary V., Christoffels A.,
RA   Clutterbuck D.R., Crowe M.L., Dalla E., Dalrymple B.P., de Bono B.,
RA   Della Gatta G., di Bernardo D., Down T., Engstrom P., Fagiolini M.,
RA   Faulkner G., Fletcher C.F., Fukushima T., Furuno M., Futaki S.,
RA   Gariboldi M., Georgii-Hemming P., Gingeras T.R., Gojobori T., Green R.E.,
RA   Gustincich S., Harbers M., Hayashi Y., Hensch T.K., Hirokawa N., Hill D.,
RA   Huminiecki L., Iacono M., Ikeo K., Iwama A., Ishikawa T., Jakt M.,
RA   Kanapin A., Katoh M., Kawasawa Y., Kelso J., Kitamura H., Kitano H.,
RA   Kollias G., Krishnan S.P., Kruger A., Kummerfeld S.K., Kurochkin I.V.,
RA   Lareau L.F., Lazarevic D., Lipovich L., Liu J., Liuni S., McWilliam S.,
RA   Madan Babu M., Madera M., Marchionni L., Matsuda H., Matsuzawa S., Miki H.,
RA   Mignone F., Miyake S., Morris K., Mottagui-Tabar S., Mulder N., Nakano N.,
RA   Nakauchi H., Ng P., Nilsson R., Nishiguchi S., Nishikawa S., Nori F.,
RA   Ohara O., Okazaki Y., Orlando V., Pang K.C., Pavan W.J., Pavesi G.,
RA   Pesole G., Petrovsky N., Piazza S., Reed J., Reid J.F., Ring B.Z.,
RA   Ringwald M., Rost B., Ruan Y., Salzberg S.L., Sandelin A., Schneider C.,
RA   Schoenbach C., Sekiguchi K., Semple C.A., Seno S., Sessa L., Sheng Y.,
RA   Shibata Y., Shimada H., Shimada K., Silva D., Sinclair B., Sperling S.,
RA   Stupka E., Sugiura K., Sultana R., Takenaka Y., Taki K., Tammoja K.,
RA   Tan S.L., Tang S., Taylor M.S., Tegner J., Teichmann S.A., Ueda H.R.,
RA   van Nimwegen E., Verardo R., Wei C.L., Yagi K., Yamanishi H.,
RA   Zabarovsky E., Zhu S., Zimmer A., Hide W., Bult C., Grimmond S.M.,
RA   Teasdale R.D., Liu E.T., Brusic V., Quackenbush J., Wahlestedt C.,
RA   Mattick J.S., Hume D.A., Kai C., Sasaki D., Tomaru Y., Fukuda S.,
RA   Kanamori-Katayama M., Suzuki M., Aoki J., Arakawa T., Iida J., Imamura K.,
RA   Itoh M., Kato T., Kawaji H., Kawagashira N., Kawashima T., Kojima M.,
RA   Kondo S., Konno H., Nakano K., Ninomiya N., Nishio T., Okada M., Plessy C.,
RA   Shibata K., Shiraki T., Suzuki S., Tagami M., Waki K., Watahiki A.,
RA   Okamura-Oho Y., Suzuki H., Kawai J., Hayashizaki Y.;
RT   "The transcriptional landscape of the mammalian genome.";
RL   Science 309:1559-1563(2005).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 337-1476 (ISOFORM 1).
RX   PubMed=15368895; DOI=10.1093/dnares/11.3.205;
RA   Okazaki N., Kikuno R., Ohara R., Inamoto S., Koseki H., Hiraoka S.,
RA   Saga Y., Seino S., Nishimura M., Kaisho T., Hoshino K., Kitamura H.,
RA   Nagase T., Ohara O., Koga H.;
RT   "Prediction of the coding sequences of mouse homologues of KIAA gene: IV.
RT   The complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs
RT   identified by screening of terminal sequences of cDNA clones randomly
RT   sampled from size-fractionated libraries.";
RL   DNA Res. 11:205-218(2004).
RN   [5]
RP   TISSUE SPECIFICITY.
RX   PubMed=14645510; DOI=10.1128/mcb.23.24.8970-8981.2003;
RA   Nguyen M.M., Nguyen M.L., Caruana G., Bernstein A., Lambert P.F.,
RA   Griep A.E.;
RT   "Requirement of PDZ-containing proteins for cell cycle regulation and
RT   differentiation in the mouse lens epithelium.";
RL   Mol. Cell. Biol. 23:8970-8981(2003).
RN   [6]
RP   INTERACTION WITH DLL1.
RX   PubMed=15509766; DOI=10.1242/dev.01417;
RA   Wright G.J., Leslie J.D., Ariza-McNaughton L., Lewis J.;
RT   "Delta proteins and MAGI proteins: an interaction of Notch ligands with
RT   intracellular scaffolding molecules and its significance for zebrafish
RT   development.";
RL   Development 131:5659-5669(2004).
RN   [7]
RP   FUNCTION, SUBCELLULAR LOCATION, AND INTERACTION WITH FZD4; FZD7 AND VANGL2.
RX   PubMed=15195140; DOI=10.1038/sj.onc.1207817;
RA   Yao R., Natsume Y., Noda T.;
RT   "MAGI-3 is involved in the regulation of the JNK signaling pathway as a
RT   scaffold protein for frizzled and Ltap.";
RL   Oncogene 23:6023-6030(2004).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-236, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=17242355; DOI=10.1073/pnas.0609836104;
RA   Villen J., Beausoleil S.A., Gerber S.A., Gygi S.P.;
RT   "Large-scale phosphorylation analysis of mouse liver.";
RL   Proc. Natl. Acad. Sci. U.S.A. 104:1488-1493(2007).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-916, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Brain, Brown adipose tissue, Heart, Kidney, Liver, Lung, Spleen, and
RC   Testis;
RX   PubMed=21183079; DOI=10.1016/j.cell.2010.12.001;
RA   Huttlin E.L., Jedrychowski M.P., Elias J.E., Goswami T., Rad R.,
RA   Beausoleil S.A., Villen J., Haas W., Sowa M.E., Gygi S.P.;
RT   "A tissue-specific atlas of mouse protein phosphorylation and expression.";
RL   Cell 143:1174-1189(2010).
CC   -!- FUNCTION: Acts as a scaffolding protein at cell-cell junctions, thereby
CC       regulating various cellular and signaling processes. Cooperates with
CC       PTEN to modulate the kinase activity of AKT1. Its interaction with
CC       PTPRB and tyrosine phosphorylated proteins suggests that it may link
CC       receptor tyrosine phosphatase with its substrates at the plasma
CC       membrane. In polarized epithelial cells, involved in efficient
CC       trafficking of TGFA to the cell surface. Regulates the ability of LPAR2
CC       to activate ERK and RhoA pathways. Regulates the JNK signaling cascade
CC       via its interaction with FZD4 and VANGL2. {ECO:0000269|PubMed:15195140,
CC       ECO:0000269|PubMed:15652357}.
CC   -!- SUBUNIT: Interacts with ADRB1, ADGRB1, LPAR2/EDG4, GRIN2B, PTEN, and
CC       PTPRB. Interacts with unidentified tyrosine phosphorylated proteins (By
CC       similarity). Interacts with FZD4, FZD7, TGFA and VANGL2. Interacts with
CC       DLL1 (PubMed:15509766). Interacts with PRRG4 (via cytoplasmic domain)
CC       (By similarity). {ECO:0000250|UniProtKB:Q5TCQ9,
CC       ECO:0000250|UniProtKB:Q9JK71, ECO:0000269|PubMed:15195140,
CC       ECO:0000269|PubMed:15509766, ECO:0000269|PubMed:15652357}.
CC   -!- INTERACTION:
CC       Q9EQJ9; P01135: TGFA; Xeno; NbExp=4; IntAct=EBI-7455245, EBI-1034374;
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:15195140};
CC       Peripheral membrane protein {ECO:0000269|PubMed:15195140}. Cell
CC       junction, tight junction {ECO:0000269|PubMed:15195140}. Nucleus
CC       {ECO:0000250}. Note=Concentrates in specific sites at the plasma
CC       membrane and in the nucleus. In epithelial cells, it localizes at tight
CC       junctions (By similarity). {ECO:0000250}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q9EQJ9-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9EQJ9-2; Sequence=VSP_034288, VSP_034289;
CC   -!- TISSUE SPECIFICITY: Widely expressed. Colocalizes with TGFA in neurons
CC       in the cortex and dentate gyrus, as well as in ependymal cells and some
CC       astrocytes (at protein level). Present in lens epithelium.
CC       {ECO:0000269|PubMed:14645510, ECO:0000269|PubMed:15652357}.
CC   -!- SIMILARITY: Belongs to the MAGUK family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAD32503.1; Type=Miscellaneous discrepancy; Note=The sequence differs from that shown because it seems to be derived from a pre-mRNA.; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF213258; AAG43836.1; -; mRNA.
DR   EMBL; AC162922; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CU210868; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AK030083; BAC26773.1; -; mRNA.
DR   EMBL; AK173225; BAD32503.1; ALT_SEQ; Transcribed_RNA.
DR   CCDS; CCDS17699.1; -. [Q9EQJ9-2]
DR   CCDS; CCDS51031.1; -. [Q9EQJ9-1]
DR   RefSeq; NP_598614.1; NM_133853.3. [Q9EQJ9-2]
DR   SMR; Q9EQJ9; -.
DR   BioGRID; 221259; 2.
DR   IntAct; Q9EQJ9; 8.
DR   MINT; Q9EQJ9; -.
DR   STRING; 10090.ENSMUSP00000112934; -.
DR   iPTMnet; Q9EQJ9; -.
DR   PhosphoSitePlus; Q9EQJ9; -.
DR   jPOST; Q9EQJ9; -.
DR   PaxDb; Q9EQJ9; -.
DR   PeptideAtlas; Q9EQJ9; -.
DR   PRIDE; Q9EQJ9; -.
DR   ProteomicsDB; 292081; -. [Q9EQJ9-1]
DR   ProteomicsDB; 292082; -. [Q9EQJ9-2]
DR   Antibodypedia; 1896; 70 antibodies.
DR   Ensembl; ENSMUST00000064371; ENSMUSP00000067932; ENSMUSG00000052539. [Q9EQJ9-2]
DR   Ensembl; ENSMUST00000122303; ENSMUSP00000113713; ENSMUSG00000052539. [Q9EQJ9-2]
DR   GeneID; 99470; -.
DR   KEGG; mmu:99470; -.
DR   UCSC; uc008qua.2; mouse. [Q9EQJ9-2]
DR   CTD; 260425; -.
DR   MGI; MGI:1923484; Magi3.
DR   eggNOG; KOG0707; Eukaryota.
DR   eggNOG; KOG3209; Eukaryota.
DR   GeneTree; ENSGT00940000156496; -.
DR   HOGENOM; CLU_004562_1_0_1; -.
DR   InParanoid; Q9EQJ9; -.
DR   OMA; ANRSRGQ; -.
DR   PhylomeDB; Q9EQJ9; -.
DR   BioGRID-ORCS; 99470; 2 hits in 52 CRISPR screens.
DR   ChiTaRS; Magi3; mouse.
DR   PRO; PR:Q9EQJ9; -.
DR   Proteomes; UP000000589; Chromosome 3.
DR   RNAct; Q9EQJ9; protein.
DR   Bgee; ENSMUSG00000052539; Expressed in dorsal root ganglion and 274 other tissues.
DR   Genevisible; Q9EQJ9; MM.
DR   GO; GO:0005923; C:bicellular tight junction; IEA:UniProtKB-SubCell.
DR   GO; GO:0030054; C:cell junction; ISO:MGI.
DR   GO; GO:0005911; C:cell-cell junction; IDA:MGI.
DR   GO; GO:0005737; C:cytoplasm; IBA:GO_Central.
DR   GO; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell.
DR   GO; GO:0005886; C:plasma membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0005109; F:frizzled binding; IPI:MGI.
DR   GO; GO:0060090; F:molecular adaptor activity; IEA:InterPro.
DR   GO; GO:0043507; P:positive regulation of JUN kinase activity; IGI:MGI.
DR   GO; GO:0046328; P:regulation of JNK cascade; IEA:InterPro.
DR   GO; GO:0007165; P:signal transduction; IBA:GO_Central.
DR   CDD; cd00201; WW; 2.
DR   Gene3D; 2.30.42.10; -; 6.
DR   InterPro; IPR008145; GK/Ca_channel_bsu.
DR   InterPro; IPR008144; Guanylate_kin-like_dom.
DR   InterPro; IPR020590; Guanylate_kinase_CS.
DR   InterPro; IPR030035; MAGI3.
DR   InterPro; IPR027417; P-loop_NTPase.
DR   InterPro; IPR001478; PDZ.
DR   InterPro; IPR036034; PDZ_sf.
DR   InterPro; IPR001202; WW_dom.
DR   InterPro; IPR036020; WW_dom_sf.
DR   PANTHER; PTHR10316:SF10; PTHR10316:SF10; 1.
DR   Pfam; PF00625; Guanylate_kin; 1.
DR   Pfam; PF00595; PDZ; 4.
DR   Pfam; PF00397; WW; 2.
DR   SMART; SM00072; GuKc; 1.
DR   SMART; SM00228; PDZ; 6.
DR   SMART; SM00456; WW; 2.
DR   SUPFAM; SSF50156; SSF50156; 6.
DR   SUPFAM; SSF51045; SSF51045; 2.
DR   SUPFAM; SSF52540; SSF52540; 1.
DR   PROSITE; PS00856; GUANYLATE_KINASE_1; 1.
DR   PROSITE; PS50052; GUANYLATE_KINASE_2; 1.
DR   PROSITE; PS50106; PDZ; 6.
DR   PROSITE; PS01159; WW_DOMAIN_1; 2.
DR   PROSITE; PS50020; WW_DOMAIN_2; 2.
PE   1: Evidence at protein level;
KW   Alternative splicing; ATP-binding; Cell junction; Cell membrane; Membrane;
KW   Nucleotide-binding; Nucleus; Phosphoprotein; Reference proteome; Repeat;
KW   Tight junction.
FT   CHAIN           1..1476
FT                   /note="Membrane-associated guanylate kinase, WW and PDZ
FT                   domain-containing protein 3"
FT                   /id="PRO_0000341408"
FT   DOMAIN          18..108
FT                   /note="PDZ 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00143"
FT   DOMAIN          116..290
FT                   /note="Guanylate kinase-like"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00100"
FT   DOMAIN          296..329
FT                   /note="WW 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00224"
FT   DOMAIN          342..375
FT                   /note="WW 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00224"
FT   DOMAIN          413..495
FT                   /note="PDZ 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00143"
FT   DOMAIN          581..657
FT                   /note="PDZ 3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00143"
FT   DOMAIN          729..811
FT                   /note="PDZ 4"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00143"
FT   DOMAIN          852..939
FT                   /note="PDZ 5"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00143"
FT   DOMAIN          1022..1104
FT                   /note="PDZ 6"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00143"
FT   NP_BIND         123..130
FT                   /note="ATP"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00100"
FT   REGION          18..108
FT                   /note="Interaction with ADRB1 and TGFA"
FT                   /evidence="ECO:0000269|PubMed:15652357"
FT   REGION          413..495
FT                   /note="Interaction with PTEN"
FT                   /evidence="ECO:0000250"
FT   REGION          729..811
FT                   /note="Interaction with ADGRB1"
FT                   /evidence="ECO:0000250"
FT   REGION          852..939
FT                   /note="Interaction with LPAR2 and GRIN2B"
FT                   /evidence="ECO:0000250"
FT   COMPBIAS        6..9
FT                   /note="Poly-Lys"
FT   COMPBIAS        240..245
FT                   /note="Poly-Glu"
FT   MOD_RES         236
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:17242355"
FT   MOD_RES         598
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q5TCQ9"
FT   MOD_RES         702
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9JK71"
FT   MOD_RES         833
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q5TCQ9"
FT   MOD_RES         916
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:21183079"
FT   MOD_RES         1321
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9JK71"
FT   VAR_SEQ         1112..1126
FT                   /note="DWDTNSPSSSNVIYD -> LAPSGLCSYVKPEQH (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:15652357,
FT                   ECO:0000303|PubMed:16141072"
FT                   /id="VSP_034288"
FT   VAR_SEQ         1127..1476
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:15652357,
FT                   ECO:0000303|PubMed:16141072"
FT                   /id="VSP_034289"
FT   CONFLICT        625
FT                   /note="I -> N (in Ref. 3; BAC26773)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   1476 AA;  161672 MW;  A9F041B5EA4B6F3F CRC64;
     MSKTLKKKKH WLSKVQECAV SWAGPPGDLG AEIRGGAERG EFPYLGRLRD EAGGGGGTCC
     VVSGKAPSPG DVLLEVNGTP VSGLTNRDTL AVIRHFREPI RLKTVKPGKV INKDLRHYLS
     LQFQKGSIDH KLQQVIRDNL YLRTIPCTTR APRDGEVPGV DYNFISVEQF KALEESGALL
     ESGTYDGNFY GTPKPPAEPS PFQPDPVDQV LFDNEFDTES QRKRTTSVSK MERMDSSLPE
     EEEDEDKEAV NGSGSMETRE MHSETSDCWM KTVPSYNQTN SSMDFRNYMM RDENLEPLPK
     NWEMAYTDTG MIYFIDHNTK TTTWLDPRLC KKAKAPEDCE DGELPYGWEK IEDPQYGTYY
     VDHLNQKTQF ENPVEEAKRK KQLGQAEIHS AKTDVERAHF TRDPSQLKGV LVRASLKKST
     MGFGFTIIGG DRPDEFLQVK NVLKDGPAAQ DGKIAPGDVI VDINGNCVLG HTHADVVQMF
     QLVPVNQYVN LTLCRGYPLP DDSEDPVVDI VAATPVINGQ SLTKGETCMN TQDFKLGAMV
     LDQNGKSGQI LASDRLNGPS ESSEQRASLA SSGSSQPELV TIPLIKGPKG FGFAIADSPT
     GQKVKMILDS QWCQGLQKGD IIKEIYHQNV QNLTHLQVVE VLKQFPVGAD VPLLILRGGP
     CSPTKTAKTK TDTKENSGSL ETINEPIPQP MPFPPSIIRS GSPKLDPSEV YLKSKTLYED
     KPPNTKDLDV FLRKQESGFG FRVLGGDGPD QSIYIGAIIP LGAAEKDGRL RAADELMCID
     GIPVKGKSHK QVLDLMTTAA RNGHVLLTVR RKIFYGEKQP EDESHQAFSQ NGSPRLNRAE
     LPTRSAPQEA YDVTLQRKEN EGFGFVILTS KSKPPPGVIP HKIGRVIDGS PADRCGGLKV
     GDHISAVNGQ SIVDLSHDNI VQLIKDAGVT VTLTVVAEEE HHGPPSGTNS ARQSPALQHR
     PMGQAQANHI PGDRIALEGE IGRDVCSSYR HSWSDHKHLA QPDTAVISVV GSRHNQSLGC
     YPVELERGPR GFGFSLRGGK EYNMGLFILR LAEDGPAIKD GRIHVGDQIV EINGEPTQGI
     THTRAIELIQ AGGNKVLLLL RPGTGLIPDH GDWDTNSPSS SNVIYDEQPP PLPSSHSAST
     FEESHVPATE DSLTRVQICE KAEELKDTVQ EKKSTLNGSQ PEMKYQSVHK TMSKKDPPRG
     SGHGEKSRLK GENGVTRRGR SASPKKSVNR HSEEHLEKIP RPLKSDPKEK SRDRSLSPRK
     GESKGRLTIK AGSGQDPYRK DRGRSSSPKK QQKIGGNSLS NTEGKLSEAG SRRAAGHPRD
     STEQLPDGRE KSGVSRKDLK QSQPGKTRTK SPEKKSSKVD ETSLPSKKTS STAGRVVSEK
     EKGKKPTAGE TSRETVEHTQ ISAKQLKQEA QEKTALGNAD DHKGRESEVT DRCRERAGCT
     PQSSSLVKKA PITPGPWRVP RANKVTGTTG MADKQL
//
